Company / Operating Cash Flow
Praxis Precision Medicines, Inc. Operating Cash Flow History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$249.1M
FY2025
5-year range
-$249.1M / -$111.1M
FY2021-FY2025
Trend
-89.0%
vs FY2024
Sector context
#182 of 216
Health Care
What the data says
Praxis Precision Medicines, Inc.'s operating cash flow of -$249M is lower than 84% of companies in the Health Care sector (FY2025). Declined from -$111M to -$249M over the past 2 years.
Based on SEC 10-K filings.
-$249M in FY2025.
Declined from -$111M to -$249M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 16% in Health CareTop 84% of 216This company -$249.1M Sector average $658.7M
▼
-137.8% below sector average
Key checks
Key Insights
- In FY2025, operating cash flow decreased 89.0% year-over-year.
- Ranks #182 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 4.48 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$249.1M | -89.0% |
| FY2024 | -$131.8M | -18.6% |
| FY2023 | -$111.1M | +39.9% |
| FY2022 | -$185.0M | -48.6% |
| FY2021 | -$124.6M | -136.7% |
| FY2020 | -$52.6M | -57.5% |
| FY2019 | -$33.4M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026